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Abstract
Resistance to anoikis (matrix deprivation-induced apoptosis) is a critical component of the 
metastatic cascade. Molecular mechanisms underlying resistance to anoikis have not been reported 
in thyroid cancer cells. For an in vitro model of anoikis, we cultured follicular, papillary, and 
anaplastic thyroid cancer cell lines on poly-HEMA-treated low-adherent plates. We also 
performed immunohistochemical analysis of human cancer cells that had infiltrated blood and/or 
lymphatic vessels. Matrix deprivation was associated with establishment of contacts between 
floating thyroid cancer cells and formation of multi-cellular spheroids. This process was 
associated with activation of gap junctional transfer. Increased expression of the gap junction 
molecule Connexin43 was found in papillary and anaplastic cancer cells forming spheroids. All 
non-adherent cancer cells showed a lower proliferation rate compared with adherent cells but were 
more resistant to serum deprivation. AKT was constitutively activated in cancer cells forming 
spheroids. Inhibition of gap junctional transfer through Connexin43 silencing, or by treatment with 
the gap junction disruptor carbenoxolone, resulted in loss of pAKT and induction of apoptosis in a 
cell-type-specific manner. In human thyroid tissue, cancer cells that had infiltrated blood vessels 
showed morphological similarity to cancer cells forming spheroids in vitro. Intra-vascular cancer 
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cells demonstrated prominent AKT activation in papillary and follicular cancers. Increased 
Connexin43 immunoreactivity was observed only in intra-vascular papillary cancer cells. Our data 
demonstrate that establishment of inter-cellular communication contributes to thyroid cancer cell 
resistance to anoikis. These findings suggest that disruption of gap junctional transfer could 
represent a potential therapeutic strategy for prevention of metastases.
Introduction
Metastasis comprises a multitude of events, including tumor cell invasion of the surrounding 
tissue and intravasation into the lymphatic or systemic vasculature, survival in a non-
adherent environment, extravasation from vessels, and ‘seeding’ at a distant site. Numerous 
observations support the notion that epithelial to mesenchymal transition (EMT) plays a 
central role in cancer cell invasion (Thiery 2002). During progression to metastatic 
competence, carcinoma cells change their adhesive properties, activate proteolysis, and 
become motile, allowing them to leave the primary tumor.
With dissemination away from the tissue origin into the lymphatic or vascular compartment, 
tumor cells are confronted by an environment deprived of normal physiological adhesion 
signals. Epithelial cells have very low survival rates in the circulation, and loss of contact 
with the extra-cellular matrix causes epithelial cells to undergo programmed cell death, 
termed anoikis (Wang 2004). Matrix-independent survival of metastatic cancer cells during 
passage through the lymph and/or blood compartment is a critical component of the 
metastatic cascade. It has been shown that in malignant lesions, cancer cell sub-populations 
selected for increased metastatic potential demonstrate an increased resistance to anoikis 
compared with the parental cells (Liotta & Kohn 2004).
The survival of carcinoma cells in a suspension culture system is considered to be a model 
of anoikis resistance. Gene expression profiling of anoikis-resistant cancer cells shows over-
expression of genes coding for cell adhesion molecules but down-regulation of molecules 
controlling cell cycle progression (Zhang et al. 2008). In addition, cells growing in 
suspension show activation of oncogenic receptor tyrosine kinases and their downstream 
signaling pathways, contributing to anchorage-independent survival. The critical role of 
phosphatidylinositol 3-kinase (PI3K)/AKT signaling in anchorage-independent survival and 
growth has been demonstrated in multiple cancer cell lines. It has been shown that cells 
transfected with constitutively active forms of either PI3K or AKT do not undergo anoikis, 
whereas inhibition of PI3K induces anoikis (Khwaja et al. 1997). Transcriptional repression 
of phosphate and tensin homolog (PTEN) located on chromosome 10 results in constitutive 
AKT activation and may also play a role in the development of anoikis resistance (Chappell 
et al. 2005).
Thyroid cancer is a common endocrine malignancy and many thyroid cancer patients present 
with metastases at the time of surgery. We previously demonstrated that thyroid cancer cells 
in the invasive front of human tumors undergo EMT and that metastatic thyroid cancers are 
characterized by over-expression of mesenchymal markers such as osteopontin and vimentin 
(Vasko et al. 2007). In addition, activation of the PI3K/AKT pathway plays an important role 
in thyroid cancer progression (Hou et al. 2007), and nuclear activation of AKT has been 
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described in thyroid cancer cells invading into adjacent tissues (Vasko et al. 2004). Much 
less is known about the mechanisms that allow thyroid cancer cell survival as they detach 
from the primary tumor and invade into blood vessels.
In this study, we sought to characterize the behavior of thyroid cancer cells that lose their 
attachment to an extra-cellular matrix. In an effort to define the molecular mechanisms 
involved in resistance of thyroid cancer cells to anoikis, we compared anti-apoptotic 
signaling pathways in thyroid cancer cell lines growing in adherent and low-adherent 
conditions. Finally, to confirm our in vitro findings, we examined human thyroid tissue 
samples using immunohistochemical analysis of cancer cells that had invaded into blood or 
lymphatic vessels.
Materials and methods
Human thyroid tissue and cell culture
The protocol was approved by the Human Use Committee at the Uniformed Services 
University of the Health Sciences and conformed to the standards of human research from 
the Helsinki Mandate. Paraffin-embedded thyroid tissue samples were obtained from 35 
papillary thyroid cancers (PTCs) and ten follicular thyroid cancers (FTCs).
Human thyroid cancer cell lines derived from FTC (FTC133 and WRO-82), follicular cancer 
metastases (FTC236 and FTC238), PTC (TPC1, BCPAP, and KTC1), and anaplastic cancer 
(SW1736) were obtained from Dr Motoyasu Saji (The Ohio State University) with 
permission from the researchers who originally established the cell lines. All cell lines had 
been tested and authenticated by DNA analysis to be of thyroid origin (Schweppe et al. 
2008). In our laboratory, we examined expression of PAX8 and TTF1 to confirm thyroid 
origin of these cell lines. These cell lines express common thyroid oncogenes including 
BRAF V600E (BCPAP, KTC1, and SW1736) or RET/PTC1 (TPC1; Schweppe et al. 2008) 
or have loss of PTEN expression (FTC133; Weng et al. 2001). In our laboratory, we 
examined expression of PTEN by western blot and, consistent with previous reports, PTEN 
protein was not detected in FTC133 cells as well as in FTC236 and FTC238 cell lines that 
derived from the metastatic lesions of the same patient.
Cancer cells were propagated in RPMI 1640 medium (Invitrogen) supplemented with 5% of 
fetal bovine serum. Cells were maintained in either adherent cell culture plates or low-
adherent cell culture conditions (poly-HEMA-treated plates). A pharmacological inhibitor of 
PI3K/AKT signaling (LY-294002), an inducer of cell cycle arrest (docetaxel), a gap junction 
disruptor (carbenoxolone), a glucocorticoid (dexamethasone), and a mineralocorticoid 
(aldosterone) were obtained from Sigma Chemical Co. LY303511 (the structural analog of 
LY-294002 which does not inhibit PI3K) was obtained from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA).
siRNA transfections
FTC133, TPC1, BCPAP, and SW1736 cells were transfected with Connexin43-specific 
siRNAs (Invitrogen #1320003) or with Stealth RNAi siRNA-negative control. To avoid non-
specific effects, experiments were performed with three different types of Connexin43 
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siRNAs. RNAi duplex–Lipofectamine complexes were prepared using RNAiMAX 
transfection reagent (Invitrogen). The efficiency of silencing was assessed by detection of 
Connexin43 mRNA using quantitative real-time PCR and western blot. Assays were 
performed 48 h after the beginning of the transfections.
Cell proliferation and cell viability assays
Cell proliferation rate was determined by cell counting using Vi-CELL Cell Viability 
Analyzer from Beckman Coulter (Fullerton, CA, USA). Cell viability was determined by 
evaluation of mitochondrial membrane potential with a fluorogenic lipophilic cation (JC-1; 
Cayman Chemical Company, Ann Arbor, MI, USA). In cells with high mitochondrial 
potential, JC-1 spontaneously forms complexes (J aggregates) with intense red fluorescence 
at 570–610 nm. In cells with low mitochondrial potential, JC-1 remains in a monomeric 
form that fluoresces green at 535 nm. Detection of mitochondrial membrane potential was 
performed according to the manufacturer’s instructions followed by fluorescent microscopy. 
The ratio between intensity of red and green fluorescent signals was calculated to determine 
the relative cell viability. Dead cells were also detected using propidium iodine staining. All 
experiments were repeated at least three times, and the average values ± S.D. of 
representative experiments are reported.
Cell dye transfer assay
Gap junction function was evaluated as described by Goldberg et al. (1995). Gap junction 
intercellular communication was followed by labeling cells with calcein–acetoxymethyl 
ester (calcein AM). Once inside the cell, calcein AM is cleaved by non-specific esterases 
into calcein, which can no longer diffuse across the cell membrane, but with a molecular 
weight of 994 Da can be transferred through gap junctions from donor cells to recipient 
cells. Donor cells were labeled with 1 μM calcein AM (Invitrogen) for 20 min at room 
temperature and visualized by fluorescent microscopy. Donor cells were also labeled with 2 
μM CM-DiI, a red fluorescent dye that does not transfer between cells. Labeled donor and 
unlabeled recipient cells were then trypsinized and seeded onto adherent or low-adherent 
plates at a 1:10 donor/recipient ratio and examined by fluorescent microscopy at 6, 12, and 
24 h. For each experimental condition, the average number of calcein-containing cells was 
determined by microscopy and normalized to that of control cultures. Flow cytometry was 
performed using BD LSRII cell analytic flow cytometer to calculate the average number of 
cells that received calcein from donor cells.
RNA extraction and quantitative RT-PCR
Total RNA was isolated from thyroid cancer cells using RNeasy Mini Kit (Qiagen) 
according to the manufacturer’s protocol. SYBR green-based qPCR master mixes were 
obtained from SuperArray Bioscience Corporation (Frederick, MD, USA).
Quantitative RT-PCR screening of genes with an established role in cancer was performed 
using the Cancer Drug Resistance & Metabolism PCR Array (PAHS-004) and Angiogenesis 
PCR Array (PAHS-024) from SuperArray Bioscience Corporation.
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Protein extraction and western blot analysis
Thyroid cancer cells were incubated with ice-cold cell lysis buffer, scraped, centrifuged, and 
the supernatant was stored at −80 °C. Twenty-five micrograms of total protein lysate were 
suspended in reduced SDS sample buffer and the lysates were subjected to SDS–PAGE (4–
12%). The separated proteins were transferred to a nitrocellulose membrane (Invitrogen) by 
electrophoretic blotting.
Membranes were incubated overnight with the primary antibody against vimentin and β-
actin (Sigma–Aldrich, Inc.), p-AKT1/2/3 (Ser473), total AKT, and cleaved caspase 3 (Cell 
Signaling Technology Danvers, MA, USA); N-Cadherin, E-Cadherin, Connexin43, 
Connexin31, integrins α6, and β4; cyclin D1 (Santa Cruz Biotechnology); and p27 (BD 
Biosciences Pharmingen, San Diego, CA, USA).
Immunodetection of proteins was performed using the Li-Cor Odyssey imaging system (LI-
COR Biosciences, Lincoln, NE, USA). After normalization to the level of β-actin, 
quantification of Connexin43 protein was performed.
Immunostaining
Immunostaining was performed on paraffin-embedded tissue sections. Endogenous 
peroxidase activity was quenched by incubation in 3% hydrogen peroxide. Sections were 
incubated overnight with primary antibodies and immunostaining was performed using the 
Vector Universal Kit (Vector Laboratories, Burlingame, CA, USA) according to the 
manufacturer’s instruction.
For immunostaining of cancer cell lines, adherent thyroid cancer cells were cultured 
overnight on eight-chambered SuperCell Culture Slides (Fisher Scientific, Pittsburgh, PA, 
USA) and then fixed in formalin for 15 min. Non-adherent cells were transferred from 
suspension to slides using a standard cytospin protocol and then fixed in formalin for 15 
min. After washing, cells were incubated overnight at 4 °C with anti-pAKT1/2/3 (Ser473) or 
anti-p27 antibody. Slides were then incubated at room temperature for 1 h with species-
specific Alexa 488-conjugated secondary antibody.
Results
Thyroid cancer cells form multi-cellular spheroids in low-adherent condition
In adherent conditions, all examined thyroid cancer cell lines at 50% of confluency 
demonstrated spindle, mesenchymal-like morphology and a single cell pattern of growth. In 
low-adherent conditions, thyroid cancer cells established cell-to-cell contacts and formed 
multi-cellular spheroids. In FTC and ATC cells, formation of intercellular contacts was 
delayed compared to PTC-derived cells, but all thyroid cancer cell lines formed spheroids by 
24 h after plating (Fig. 1A).
There was no evidence of cell death in thyroid cancer cells forming spheroids as determined 
by propidium iodine staining (data not shown). The viability of thyroid cancer cells in 
spheroids was assessed by detection of mitochondrial membrane potential using JC-1 
staining. In all cell lines growing in low-adherent conditions, we observed formation of J 
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aggregates, indicating that these cells were viable (Fig. 1B). Thyroid cancer cells forming 
spheroids were able to adhere and restored a single cell pattern of growth after re-plating on 
the regular adherent plates (Fig. 1C).
Expression of adhesion molecules in thyroid cancer cell forming spheroids
Establishment of cell-to-cell contacts and the morphological changes in thyroid cancer cells 
that we observed during growth in low-adherent conditions suggested the potential role of 
cell adhesion molecules in the formation of spheroids. Analysis of previously published 
micro-array data (Vasko et al. 2007) revealed a differential expression of cell adhesion 
molecules (N-cadherin, integrin α6, integrin β4, Connexin31, and Connexin43) in human 
thyroid cancers compared to corresponding normal thyroid tissue. Therefore, we compared 
expression of these molecules in thyroid cancer cells forming spheroids and in 
corresponding adherent cells. The level of N-cadherin, integrin α6, integrin β4, and 
Connexin31 was not significantly different between adherent and non-adherent thyroid 
cancer cells (Supplementary Figure 1, see section on supplementary data given at the end of 
this article).
However, Connexin43 was differently expressed in cancer cell lines growing in adherent 
versus non-adherent conditions (Fig. 2A). Quantification of Connexin43 expression was 
performed after normalization to β-actin and results are summarized in Fig. 2B. Connexin43 
expression was significantly increased in PTC- and ATC-derived thyroid cancer cell lines, 
but not in FTC-derived cancer cells. We also compared intracellular localization of 
Connexin43 in thyroid cancer cells growing on adherent plates and in low-adherent 
conditions. Immunostaining revealed cytoplasmic localization of Connexin43 in all 
examined thyroid cells growing on adherent plate, but predominantly membranous 
localization of Connexin43 in thyroid cancer cells growing in low-adherent conditions (Fig. 
2C).
Activation of gap junctional intercellular transfer in thyroid cancer cell forming spheroids
Translocation of Connexin43 to the cell membrane in all cancer cells forming spheroids 
suggested that Connexin43-mediated gap junctional intercellular transfer (GJIT) could be 
induced in these cells. To determine the level of GJIT in thyroid cancer cells forming 
spheroids, we performed a fluorogenic dye transfer assay. Microscopy showed that calcein 
transfer from donor to recipient cells was higher in cancer cells forming spheroids compared 
with adherent cells (Fig. 3A). Quantification of calcein transfer was performed in cancer 
cells growing in adherent and low-adherent conditions and results are presented in Fig. 3B. 
The level of GJIT in PTC-derived cells forming spheroids was higher than that in other 
examined cell lines.
Together, these data showed that Connexin43 membranous re-localization with subsequent 
induction of GJIT is a common event in all examined thyroid cancer cells forming spheroids.
Growth of thyroid cancer cells in low-adherent condition
Since formation of cell-to-cell contacts is a known factor controlling cancer cell 
proliferation, we then examined the pattern of thyroid cancer cell growth in adherent and 
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low-adherent conditions. Growth of adherent TPC1, FTC236, FTC238 and SW1736 cells 
was higher when compared to the corresponding cells growing in the low-adherent condition 
during 24 h after plating. Growth of adherent FTC133 and BCPAP thyroid cancer cells was 
similar to the growth of those observed on non-adherent plates during the first 24 h after 
plating. The rate of growth, however, was decreased in all non-adherent cells incubated for 
48, 72 and 96 h compared to adherent cells (Fig. 4A). Despite a decreased rate of growth, 
the viability of non-adherent cells, as determined by JC-1 staining, was not affected.
We also examined the pattern of thyroid cancer cell growth in serum-free medium. Serum 
deprivation was associated with progressive decrease in cell number and loss of viability in 
all examined cell lines cultured on adherent plates (Fig. 4B). In contrast, growth and 
viability of thyroid cancer cells cultured on low-adherent plates were not significantly 
affected by serum deprivation. Thyroid cancer cells growing in low-adherent condition were 
able to survive for up to 4 weeks without serum supplementation and restored growth after 
re-plating on adherent plate.
Flow cytometry showed that growth in low-adherent condition was associated with an 
increased proportion of cells in the G1 phase of the cell cycle and a decreased number of 
cells in G2/M phases. The proportion of cells in the sub-G1 phase was not different between 
adherent and non-adherent cells (data not shown). A common feature for all cancer cells 
forming spheroids was increased nuclear expression of p27 compared with corresponding 
adherent cells (Fig. 4C). The proportion of thyroid cancer cells showing nuclear expression 
of p27 in adherent and non-adherent condition was established by microscopic analysis of at 
least 250 cells in each of examined thyroid cancer cell lines and results are summarized in 
Fig. 4D.
Different patterns of thyroid cancer cell growth in adherent and low-adherent conditions 
were associated with different responses to a chemotherapeutical compound targeting 
proliferating cancer cells. In all examined thyroid cancer cells, treatment with docetaxel (10 
μM for 24 h) was associated with changes in nuclear morphology. Treatment with docetaxel 
for 48 h induced cell death in adherent thyroid cancer cells but had limited effects on cancer 
cells cultured in low-adherent conditions (Supplementary Figure 2, see section on 
supplementary data given at the end of this article).
Together, these results showed that thyroid cancer cells growing in low-adherent conditions 
are characterized by a decreased proliferation rate and are more resistant to apoptotic stimuli 
compared with adherent cells.
Activation of anti-apoptotic signaling in thyroid cancer cell spheroids
The level of AKT activation in adherent thyroid cancer cells and in cell spheroids was 
examined by western blot and immunostaining. In FTC133, FTC236, FTC238, and TPC1 
cancer cells growing in complete medium, the level of activated AKT was not significantly 
different between adherent and non-adherent cells (Fig. 5A). In BCPAP, KTC1, and 
SW1736 thyroid cancer cells, loss of attachment to extra-cellular matrix was associated with 
increased AKT activation. Serum deprivation was associated with a decrease in pAKT in 
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adherent cells. However, a high level of pAKT was detected in non-adherent thyroid cancer 
cells cultured in serum-free medium (Fig. 5A and 5B).
To confirm the role of PI3K/AKT signaling in resistance to anoikis, we examined the effect 
of LY294002 and its structural analog LY303511. Differential response to PI3K/AKT 
inhibitor was observed in thyroid cancer cells expressing a high level of PTEN (WRO, 
TPC1, BCPAP, and SW1736) and in PTEN-deficient cells (FTC133, FTC236, and FTC238). 
In PTEN-expressing thyroid cancer cell lines, treatment with LY294002 (10 μM for 24 h), 
but not with LY303511 (10 μM for 24 h), was associated with decreased activation of AKT 
(Fig. 5C). Inhibition of pAKT by LY294002 in non-adherent thyroid cancer cells was 
associated with induction of apoptosis in RET/PTC-positive cells (TPC1) as well as in 
BRAF mutant cell lines (BCPAP, KTC1, and SW1736).
In PTEN-deficient cells (FTC133, FTC236, and FTC238), treatment with LY294002 (10 μM 
for 24 h) resulted in minor inhibition of pAKT. However, extended treatment with 
LY294002 for 48 h or at increased concentration (20 μM) resulted in inhibition of pAKT and 
induction of apoptosis in these cell lines (data not shown). Treatment with LY303511 did not 
induce apoptosis in any examined cells growing on adherent or low-adherent plates.
Together, these results showed that activation of PI3K/AKT signaling plays a role in thyroid 
cancer cell resistance to anoikis.
Silencing of Connexin43 and thyroid cancer cell resistance to anoikis
Gap junctions serve as a conduit of inter-cellular transfer of messengers that can potentially 
activate AKT signaling; therefore, we hypothesized that there may be a link between 
activation of GJIT and resistance to anoikis in thyroid cancer cells. We first investigated 
whether inhibition of Connexin43 expression in thyroid cancer cell lines could affect their 
viability in low-adherent conditions. FTC133, TPC1, BCPAP, and SW1736 cells were 
transfected with Connexin43-specific siRNA or with scramble siRNA. The efficiency of 
transfection was evaluated with BLOCK-iT Fluorescent Oligo and ranged from 60 to 75%. 
The mRNA level of Connexin43 was inhibited by 25.6 ± 1.8-fold in FTC133, 10.2 ± 1.4-
fold in TPC1, 17.2 ± 1.6-fold in BCPAP, and 21.3 ± 1.2-fold in SW1736 cells compared 
with corresponding cells transfected with scramble siRNA. The downregulation of 
Connexin43 was also confirmed by western blot analysis (Fig. 6A).
In adherent conditions, silencing of Connexin43 was not associated with inhibition of pAKT 
in any of the examined thyroid cancer cell lines. In low-adherent conditions, inhibition of 
Connexin43 had no effect on AKT activation in PTEN-deficient FTC133 cells. However, in 
TPC1, BCPAP, and SW1736 cells growing in low-adherent conditions, silencing of 
Connexin43 was associated with decrease in pAKT (Fig. 6B).
The viability of FTC133 cells in low-adherent condition was not significantly affected by 
Connexin43 silencing (Fig. 6C). The viability of TPC1, BCPAP, and SW1736 cells in low-
adherent conditions was decreased after Connexin43 silencing.
Together, these data showed that Connexin43 has a variable contribution to AKT activation 
and resistance to anoikis in thyroid cancer cells lines with different oncogene mutations. 
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Resistance to anoikis was not significantly affected by the loss of Connexin43 in PTEN-
deficient cells.
Pharmacological inhibition of gap junctional communication and thyroid cancer cell 
resistance to anoikis
We also examined the effects of a pharmacological disruptor of gap junctions 
(carbenoxolone) on thyroid cancer cells growing in adherent and low-adherent conditions. 
Carbenoxolone is reported to be effective as a gap junction uncoupler at concentrations 
ranging from as low as 3 μM to as high as 400 μM, in a cell-type-specific manner (Davidson 
et al. 1986, Bao et al. 2011). In adherent thyroid cancer cells, treatment with carbenoxolone 
(25 μM) did not affect cell viability in any of the cell lines (data not shown). In low-adherent 
conditions, carbenoxolone at 25 μM was associated with inhibition of GJIT in all cell lines, 
but most notably in PTC-derived thyroid cancer cells (Fig. 7A). Treatment of cell spheroids 
with increasing concentrations of carbenoxolone resulted in decreased cell viability in a 
dose-dependent manner (Fig. 7B). Carbenoxolone (25 μM) induced caspase cleavage in non-
adherent WRO, TPC1, BCPAP, KTC1, and SW1736 cell lines (Fig. 7C). However, in PTEN-
deficient cells (FTC133, FTC236, and FTC238), treatment with carbenoxolone from 25 to 
50 μM was not associated with induction of apoptosis. However, with carbenoxolone at a 
concentration of 100 μM, cell death occurred in all examined cell lines growing on adherent 
and low-adherent plates.
As a known inhibitor of 11 β-hydroxysteroid dehydrogenase type 2, carbenoxolone 
increases the level of cortisol, which in turn leads to activation of glucocorticoid and 
mineralocorticoid receptors. To determine whether pro-apoptotic properties of 
carbenoxolone were related to inhibition of GJIT or to stimulation of corticoid receptors, we 
examined the effects of dexamethasone and aldosterone on thyroid cancer cells formed into 
spheroids. Treatment with dexamethasone or aldosterone (1–500 nm) had no effect on the 
viability of thyroid cancer cells growing in adherent and low-adherent conditions.
These findings demonstrated a cell-type-specific response to treatment with pharmacological 
disruptor of gap junction. Carbenoxolone had limited effect on resistance to anoikis in 
PTEN-deficient thyroid cancer cells.
AKT activation and Connexin43 expression in human thyroid cancer cells that invaded 
blood and lymphatic vessels
To determine whether these in vitro findings can have relevance in vivo, we examined serial 
tissue sections from 35 human papillary and ten FTCs. Thyroid cancer cells that had 
infiltrated blood and/or lymphatic vessels (Fig. 8A) were detected in 13/45 examined cases 
(ten PTCs and three FTCs). The intra-vascular thyroid cancer cells formed nests consisting 
of various numbers of cells. These cell aggregates were found in vessels located in the areas 
of extra-thyroidal tumor extension. In FTCs, floating cancer cell nests were covered by 
endothelial layer.
The thyroid origin of intra-vascular cell nests was confirmed by immunostaining with anti-
thyroglobulin. Immunohistochemical evaluation of EMT markers (vimentin and E-cadherin) 
showed no differences between thyroid cancer cells located in the central area of tumors and 
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intra-vascular cells (data not shown). Consistent with previous studies, the intensity of 
pAKT staining was increased in the invasive front of tumors compared with cells located in 
the central part of tumors. Prominent activation of AKT was observed in intra-vascular 
thyroid cancer cells in both PTC and FTC (Fig. 8B). The level of Connexin43 expression 
was low or undetectable in all examined primary thyroid cancers. The level of Connexin43 
expression was not significantly different between FTC cells located in central area of tumor 
and in intra-vascular cancer cells. In 6/10 PTCs with evidence of vascular invasion, intra-
vascular cancer cells demonstrated increased Connexin43 immunoreactivity compared with 
cancer cells located in the central part of tumor (Fig. 8B).
Discussion
This study investigated the molecular mechanisms implicated in thyroid cancer cell 
resistance to anoikis and provides several novel findings. First, we showed that loss of extra-
cellular matrix attachment is associated with the establishment of inter-cellular contacts and 
activation of GJIT between floating thyroid cancer cells. Secondly, we demonstrated that 
thyroid cancer cells forming spheroids are characterized by decreased proliferation with 
concomitant activation of anti-apoptotic AKT signaling. Thirdly, we provided evidence that 
resistance to anoikis is dependent on activation of GJIT in a cell-type-specific manner. 
Finally, we showed that human thyroid cancer cells located in blood or lymphatic vessels 
recapitulate the morphological features of spheroids (form interconnected cell aggregates) 
and have prominent AKT activation.
As a model, we employed a suspension culture on poly-HEMA-coated plates, conditions 
that inhibit cell–matrix interaction. In these conditions, thyroid cancer cells established cell-
to-cell contacts and subsequently formed spheroid-like structures. Our findings are 
consistent with previously reported data. Formation of cancer cell aggregates has been 
reported in hepatoma, breast, prostate, and lung cancer cell lines growing in suspension 
(Berezovskaya et al. 2005, Liu et al. 2008, Zhang et al. 2008, Kochetkova et al. 2009). It has 
also been reported that formation of multi-cellular aggregates in non-adherent conditions is 
associated with over-expression of adhesion molecules (Zhang et al. 2008).
Analysis of adhesion molecules in thyroid cancer cells forming spheroids revealed the over-
expression of the gap junction molecule Connexin43 only in PTC-and ATC-derived thyroid 
cancer cells. However, membranous translocation of Connexin43 was detected in all 
examined thyroid cancer cells growing in low-adherent conditions. Functional studies using 
a fluorogenic dye revealed activation of GJIT in all examined thyroid cancer cells forming 
spheroids.
These data suggested that Connexin43 membranous translocation with subsequent activation 
of GJIT is a common event in all thyroid cancer cells forming spheroids. This observation is 
in agreement with recently published findings demonstrating the importance of membranous 
Connexin43 localization for GJIT (Bodenstine et al. 2010).
Establishment of gap junctions affects a number of physiological functions such as cell 
growth, proliferation, and differentiation (Evans & Martin 2002). We showed that formation 
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of cell-to-cell contacts between thyroid cancer cells in low-adherent condition was 
associated with decreased proliferation. We also demonstrated that cancer cells in spheroids 
are more resistant to chemotherapeutic agents targeting proliferating cancer cells compared 
with adherent cells. Similar findings were previously reported in other cancer cell models 
(Sakuma et al. 2010).
Analysis of anti-apoptotic signaling revealed that AKT is constitutively activated in thyroid 
cancer cells forming spheroids. Resistance to anoikis in BRAF mutant thyroid cancer cells 
was also associated with increased AKT activation. These findings are consistent with 
previously published data showing the role of pAKT in cancer cell resistance to anoikis 
(Khwaja et al. 1997) and corroborate results demonstrating induction of pAKT in resistant to 
anoikis BRAF-positive melanoma cell lines (Boisvert-Adamo & Aplin 2006).
Our data also suggest that mechanisms controlling AKT activation could be different in 
adherent and non-adherent cancer cells. Formation of gap junctions facilitates intercellular 
transfer of cellular messengers (glucose, Ca2+, IP3, camp, and others) that have the ability to 
activate AKT signaling. We hypothesized that inhibition of GJIT will decrease pAKT and 
sensitize thyroid cancer cells to anoikis. Silencing of Connexin43 was associated with 
decreased GJIT in thyroid cancer cells forming spheroids, especially in PTC-derived cells. 
Loss of Connexin43 was associated with inhibition of AKT activation and induction of 
apoptosis in thyroid cancer cell lines expressing a high level of PTEN. However, silencing of 
Connexin43 in a PTEN-deficient thyroid cancer cell line (FTC133 cells) was not associated 
with inhibition of pAKT and induction of apoptosis. PTEN-dexcient cells were also more 
resistant to treatment with a pharmacological disruptor of gap junctions. Together, these data 
showed that mechanisms underlying resistance to anoikis are cell-type specific and may be 
reliant on the mutation status of the examined cells, which is consistent with previously 
reported findings (Vitolo et al. 2009).
To determine whether our in vitro findings are relevant in human thyroid cancer, we 
examined human thyroid cancer cells that invaded blood or lymphatic vessels. In widely 
invasive thyroid cancers, we observed interconnected thyroid cancer cell aggregates located 
in blood or lymphatic vessels. These findings are similar to recently published data 
examining intralymphatic floating lung cancer cells (Sakuma et al. 2010). In addition to 
morphological resemblance with thyroid cancer cells forming spheroids in vitro, 
intravascular human thyroid cancer cells demonstrated prominent AKT activation. Analysis 
of Connexin43 expression in human thyroid cancers corroborated our in vitro data and 
suggested that Connexin43-mediated activation of GJIT can play a specific role in PTCs.
PTCs account for more than 80% of all thyroid cancers and are characterized by frequent 
metastatic spread to the loco-regional lymph nodes. Our data suggests that gap junction 
disruptors could target anoikis-resistant PTC cells and may have metastasis-preventive 
properties. Carbenoxolone is a water-soluble, synthetic derivative of the licorice root extract, 
18-α-glycyrrhetinic acid, which inhibits gap junction communication (Sagar & Larson 
2006). Carbenoxolone is used for the treatment of esophageal ulceration and inflammation at 
therapeutic dose of 0.714 mg/kg. Pharmacokinetic studies in humans showed that after 
administration of carbenoxolone at a dose of 4.5 mg/kg, its concentration in blood is only 
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142 nm. During treatment with these doses of carbenoxolone, blood pressure was 
significantly increased in the examined patients. The in vitro concentration necessary to 
affect anoikis is significantly higher than clinical applications have used, suggesting that it 
may be difficult to achieve a dose of carbenoxolone that would be tolerated in humans. 
However, other drugs are also known to disrupt gap junctional intercellular communication, 
to include anti-malarial (quinine and mefloquine), anti-inflammatory (fenamates), and anti-
epileptic (phenytoin) drugs. Additional studies are needed to determine the possible 
effectiveness of these compounds for induction of anoikis in cancer cells.
In summary, our in vitro and in vivo data show that formation of cell-to-cell contacts with 
subsequent activation of GJIT plays a role in AKT activation and thyroid cancer cell survival 
in low-adherent conditions. On the basis of these findings, we propose that gap junction-
mediated communication may represent a potential molecular target for prevention of 
metastases.
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Figure 1. 
Thyroid cancer cell morphology in low-adherent conditions. TPC1 cells demonstrate 
common phenomena to all cell lines. (A) Individual cells at initial plating in low-adherent 
conditions. At 24 h, each cell type was formed into multi-cellular, trabecula-like structures. 
(B) In low-adherent conditions, very low amount of fluorescence at 535 nm was seen, 
indicating a paucity of JC-1 monomers. Conversely, intense fluorescence at 570 nm was 
seen in JC-1 aggregates. (C) Cells in spheroids re-established a mesenchymal morphology 
by 24 h on adherent culture plates.
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Figure 2. 
Gap junction formation and inter-cellular communication. (A) Connexin43 (C×43) protein 
level in cancer cells grown in adherent and low-adherent conditions. (B) Graphical 
representation demonstrating induction of C×43 in low-adherent versus adherent conditions. 
(C) Increased membranous immunoreactivity of C×43 in non-adherent cell spheroids. Ad, 
adherent conditions; LA, low-adherent conditions.
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Figure 3. 
(A) Increased calcein transfer in thyroid cancer cells forming spheroids versus adherent 
cells. (B) Calcein transfer occurs in all cell lines in spheroids, with more transfer occurring 
in PTC-derived cells. Ad, adherent conditions; LA, low-adherent conditions.
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Figure 4. 
Thyroid cancer cell growth in low-adherent conditions. For (A and B), the solid lines 
indicate growth curve of adherent cells and the dashed lines are representative of low-
adherent conditions. Filled square, FTC133; filled diamond, TPC1; filled triangle, BCPAP. 
Cell growth and viability were examined by using Vi-CELL Cell Viability Analyzer. (A) 
Growth in complete media. (B) Growth in serum-free media. (C) Immunostaining indicating 
predominantly nuclear p27 in low-adherent conditions. (D) Growth in low-adherent 
condition is associated with increased number of cells with nuclear p27 expression. Ad, 
adherent conditions; LA, low-adherent conditions.
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Figure 5. 
AKT activation in thyroid cancer cells growing in adherent (A) and low-adherent (LA) 
conditions. (A) Cells were grown in complete (10%) or in serum-deprived (0%) medium and 
AKT activation was detected by western blot. (B) pAKT immunostaining in TPC1 cells 
culturing in serum-free media. (C) AKT activation in thyroid cancer cells after exposure to 
LY-294002 (10 μM) and LY-303501 (10 μM) in both adherent and low-adherent conditions. 
In non-adherent TPC1 and BCPAP cells, inhibition of pAKT was associated with induction 
of caspase cleavage. PTEN-deficient FTC cells showed increased resistance to treatment 
with LY-294002. Ad, adherent conditions; LA, low-adherent conditions.
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Figure 6. 
The effect of Connexin43 silencing on thyroid cancer cells forming spheroids in low-
adherent conditions. Scr, scramble. siCx, siRNA of C×43. (A) Gain of C×43 in low-adherent 
conditions was prevented by siRNA to C×43. (B) Loss of C×43 in non-adherent cells 
correlated with decreased AKT activation in TPC1, BCPAP, and SW1736 cells. (C) In low-
adherent conditions, C×43 silencing was associated with decreased viability in TPC1, 
BCPAP, and SW1736 cells (paucity of JC aggregates), but had limited effect on the viability 
of FTC133 cells.
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Figure 7. 
The effect of a pharmacological inhibitor of gap junctional transfer on thyroid cancer cells. 
(A) Carbenoxolone treatment decreased calcein transfer in all cell lines, most notable in 
PTC-derived cells (60–70% decrease). (B) Carbenoxolone treatment sensitized non-adherent 
TPC1 cells to anoikis in a dose-dependent manner as evidenced by the progressive loss of JC 
aggregates and accumulation of JC monomers. (C) Non-adherent cells with or without 
carbenoxolone (25 μM). Caspase cleavage induced in WRO, TPC1, BCPAP, KTC1, and 
SW1736 cells.
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Figure 8. 
Human thyroid cancer tissue samples. (A) H&E staining demonstrating intra-vascular 
thyroid cell aggregate (arrows). (B) Immunostaining with anti-pAKT and anti-C×43 
antibodies in human thyroid cancer samples.
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